These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35266828)

  • 1. Impact of Short-Term Storage on
    Okitwi M; Orena S; Thomas K; Tumwebaze PK; Byaruhanga O; Nsobya SL; Conrad MD; Bayles BR; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0143721. PubMed ID: 35266828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
    Kreutzfeld O; Tumwebaze PK; Okitwi M; Orena S; Byaruhanga O; Katairo T; Conrad MD; Rasmussen SA; Legac J; Aydemir O; Giesbrecht D; Forte B; Campbell P; Smith A; Kano H; Nsobya SL; Blasco B; Duffey M; Bailey JA; Cooper RA; Rosenthal PJ
    Microbiol Spectr; 2023 Jun; 11(3):e0523622. PubMed ID: 37158739
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kreutzfeld O; Orena S; Okitwi M; Tumwebaze PK; Byaruhanga O; Katairo T; Conrad MD; Legac J; Garg S; Crudale R; Aydemir O; Giesbrecht D; Nsobya SL; Blasco B; Duffey M; Rouillier M; Bailey JA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0046624. PubMed ID: 39136468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Varied Susceptibilities to PfATP4 Inhibitors and Genotypes in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Rasmussen SA; Ramanathan AA; Tumwebaze PK; Byaruhanga O; Katairo T; Asua V; Okitwi M; Orena S; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey J; Duffey M; Bayles BR; Vaidya AB; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0077121. PubMed ID: 34339273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of Ugandan Plasmodium falciparum Isolates to Proteasome Inhibitors.
    Garg S; Kreutzfeld O; Chelebieva S; Tumwebaze PK; Byaruhanga O; Okitwi M; Orena S; Katairo T; Nsobya SL; Conrad MD; Aydemir O; Legac J; Gould AE; Bayles BR; Bailey JA; Duffey M; Lin G; Kirkman LA; Cooper RA; Rosenthal PJ
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0081722. PubMed ID: 36094216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Tumwebaze PK; Byaruhanga O; Katairo T; Okitwi M; Orena S; Rasmussen SA; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Duffey M; Cooper RA; Rosenthal PJ
    J Infect Dis; 2022 Feb; 225(4):696-704. PubMed ID: 34460932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger.
    Issaka M; Salissou A; Arzika I; Guillebaud J; Maazou A; Specht S; Zamanka H; Fandeur T
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3415-9. PubMed ID: 23612203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug susceptibility of
    Tumwebaze PK; Katairo T; Okitwi M; Byaruhanga O; Orena S; Asua V; Duvalsaint M; Legac J; Chelebieva S; Ceja FG; Rasmussen SA; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Bayles BR; Rosenthal PJ; Cooper RA
    Lancet Microbe; 2021 Sep; 2(9):e441-e449. PubMed ID: 34553183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
    Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
    Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.
    van Schalkwyk DA; Pratt S; Nolder D; Stewart LB; Liddy H; Muwanguzi-Karugaba J; Beshir KB; Britten D; Victory E; Rogers C; Millard J; Brown M; Nabarro LE; Taylor A; Young BC; Chiodini PL; Sutherland CJ
    Clin Infect Dis; 2024 Feb; 78(2):445-452. PubMed ID: 38019958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda.
    Tumwebaze PK; Conrad MD; Okitwi M; Orena S; Byaruhanga O; Katairo T; Legac J; Garg S; Giesbrecht D; Smith SR; Ceja FG; Nsobya SL; Bailey JA; Cooper RA; Rosenthal PJ
    Nat Commun; 2022 Oct; 13(1):6353. PubMed ID: 36289202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State of Artemisinin and Partner Drug Susceptibility in
    Montenegro LM; de Las Salas B; Neal AT; Tobon-Castaño A; Fairhurst RM; Lopera-Mesa TM
    Am J Trop Med Hyg; 2021 Jan; 104(1):263-270. PubMed ID: 33289466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by
    Mbye H; Bojang F; Jawara AS; Njie B; Mohammed NI; Okebe J; D'Alessandro U; Amambua-Ngwa A
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218.
    Posayapisit N; Pengon J; Shaw PJ; Uthaipibull C; Kongkasuriyachai D; Phyo AP; Nosten F; Yuthavong Y; Kamchonwongpaisan S
    Int J Antimicrob Agents; 2023 Jul; 62(1):106838. PubMed ID: 37160237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.